Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2010
06/23/2010CN101744799A Veterinary valnemulin, novel liposome formulation of the salt thereof and preparation method thereof
06/23/2010CN101744794A New natural hypericin antiviral drug
06/23/2010CN101744782A Tablet containing faropenem sodium
06/23/2010CN101744778A Voriconazole phosphate ester for injection and preparation method thereof
06/23/2010CN101744776A Minocycline hydrochloride freeze-drying powder injection and preparation method thereof
06/23/2010CN101744773A Preparation method of bitter-free azithromycin granular composite
06/23/2010CN101744771A Method for preparing solid enrofloxacin nano particles
06/23/2010CN101744769A Methods for preparing sterile powder of cefoselis sulfate
06/23/2010CN101744763A Enrofloxacin nano emulsion and method for preparing same
06/23/2010CN101744762A Preparation method of butenafine hydrochloride liniment
06/23/2010CN101744360A Antrodia camphorata extract and cigarette containing antrodia camphorata extract
06/23/2010CN101744096A Poultry feed for enhancing orgainc antibody
06/23/2010CN101743963A Mosquito repellent and preparation method thereof
06/23/2010CN101579336B Aztreonam for injection and production method thereof
06/23/2010CN101574494B Drug for treating hepatitis B
06/23/2010CN101455764B Traditional Chinese medicine for treating zoster
06/23/2010CN101390837B Amoxicillin granule and production method thereof
06/23/2010CN101322685B Mezlocillin sodium and sulbactam sodium for injection and freeze-dried injection preparation thereof
06/23/2010CN101264181B Auxiliary treating hepatitis Chinese and Western medicines composition containing biphenyldicarboxylate and Chinese medicine extraction
06/23/2010CN101215568B Anthrax resisting polypeptide and its application and preparation method
06/23/2010CN101152190B Orally disintegrating tablets of adefovir dipivoxil and method for preparing the same
06/23/2010CN101125187B Traditional Chinese medicinal plaster for treating pulmonary tuberculosis
06/23/2010CN101104617B Dihydropyrimidine compounds and use of the same in preparing medicament for curing and preventing virosis
06/23/2010CN101104015B Olive soft capsule raw material formulation and its preparation technology
06/23/2010CN101085090B Traditional Chinese medicine lotion for treating beriberi
06/23/2010CN101053612B External applied traditional Chinese medicine vagina cleaning agent for curing gynecopathy and vagina cleaning ointment thereof
06/23/2010CN101049279B Antibacterial shampoo of Nano silver, and preparation method
06/23/2010CN101048410B HIV inhibiting bicyclic pyrimidine derivatives
06/23/2010CN101032456B Hairdressing combination made of natural vegetable and preparing method thereof
06/23/2010CN101007113B Shenling Chinese medicine preparation for treating acute and chronic hepatitis and its preparation method
06/23/2010CN101003569B Antigen epitope and mutant of lyase in gamma bacteriophage of anthrax bacillus, and application
06/22/2010US7741453 Viricides; respiratory synctia virus; parainfluenza virus; simian immunodeficiency virus; complexing drug to blood component; immobilization; storage stability
06/22/2010US7741372 Targeting p38 mitogen activated protein kinase (MAPK) cellular signaling pathway; using such as N,N'-bis(3,5-diacetylphenyl)decanediamide tetrakis(amidinohydrazone) tetrahydrochloride
06/22/2010US7741368 Approach to antimicrobial host defense with molecular shields with EPA and DHA analogs
06/22/2010US7741349 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitors for seine/threonine kinases, phosphatases; Alzheimer'
06/22/2010US7741339 Fab I inhibitors
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010US7741312 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries
06/22/2010US7741297 Cpg sites; point mutations; immunogens; cancer
06/22/2010US7741280 Multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
06/22/2010US7741274 Increasing hematopoiesis; treating glucosuria, hyperglycemia and diabetes; thrombocytopenia
06/22/2010US7741115 for modulating or altering T cell function; found on lymphoid derived dendritic cells and display a limited homology to adhesion molecules; generating natural killer cells
06/22/2010US7741076 developing genetic constructs capable of expressing lipidated rP6 in e coli; used for to preventing disease caused by Haemophilus influenzae
06/22/2010US7741057 Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor
06/22/2010US7741039 Postweaning multisystemic wasting syndrome virus from pigs
06/22/2010US7740870 Group B Streptococcus antigens and corresponding DNA fragments
06/22/2010US7740854 Treatment of macrophage mediated disease
06/22/2010US7740851 Ultra high affinity neutralizing antibodies
06/22/2010US7740842 comprising an E25 anti-IgE antibody and acetic acid ; nasal sprays and slow release formulations drying or freeze-drying; treating an allergic disease
06/22/2010US7740834 Murine zcytor17 ligand polypeptides
06/22/2010CA2586538C Nitroxy steroids
06/22/2010CA2552218C Left-side glucose lipid a analogue
06/22/2010CA2540834C Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation
06/22/2010CA2480409C Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
06/22/2010CA2441071C Tsg101-gag interaction and use thereof
06/22/2010CA2420996C Substituted heterocyclic compounds for treating multidrug resistance
06/22/2010CA2412718C Viral polymerase inhibitors
06/22/2010CA2398988C Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient
06/22/2010CA2353905C Chemotherapeutic composition and method
06/22/2010CA2331086C Hepatitis vaccine
06/22/2010CA2242878C Induction of immune response against desired determinants
06/22/2010CA2190943C Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
06/17/2010WO2010068920A2 Diaminoquinazoline inhibitors of dihydrofolate reductase
06/17/2010WO2010068760A2 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
06/17/2010WO2010068714A2 Deuterated compounds as hepatitis c virus (hcv) inhibitors
06/17/2010WO2010068708A2 3'-azido purine nucleotide prodrugs for treatment of viral infections
06/17/2010WO2010068383A1 Novel rifamycin 3, 4- (3' -substituted aminomethyl) fused pyrrolo derivatives
06/17/2010WO2010067980A2 Histone deacetylase inhibitor that reactivates hiv-1 proviruses from latently hiv-infected cells
06/17/2010WO2010067883A1 Feed for preventing and/or treating diseases due to clostridium sp. bacteria in livestock, and anti-clostridium agent
06/17/2010WO2010067869A1 Anti-viral agent and anti-viral composition
06/17/2010WO2010067671A1 Immunological reconstitution promoter or prophylactic agent for infections each of which maintains graft-versus-tumor effect
06/17/2010WO2010067332A1 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
06/17/2010WO2010067202A2 Mixing lyophilised meningococcal vaccines with non-hib vaccines
06/17/2010WO2010067201A2 MIXING LYOPHILISED MENINGOCOCCAL VACCINES WITH D-T-Pa VACCINES
06/17/2010WO2010067125A1 2- (piperidin-1-yl) -4-azolyl-thiazole-5-carboxylic acid derivatives against bacterial infections
06/17/2010WO2010067123A1 2- (piperidin-1-yl) -4-heterocyclyl-thiazole-5-carboxylic acid derivatives against bacterial infections
06/17/2010WO2010066938A1 Use of nanoparticles as cytotoxic agents
06/17/2010WO2010066931A1 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug
06/17/2010WO2010066847A1 Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-hiv agents
06/17/2010WO2010066756A1 Polymorph ii of an antifungal compound
06/17/2010WO2010066699A1 Uracyl cyclopropyl nucleotides
06/17/2010WO2010066239A1 Inhibitors of dimethylarginine dimethylaminohydrolase
06/17/2010WO2010066112A1 siRNA COMPOSITIONS AND METHODS FOR POTENTLY INHIBITING VIRAL INFECTION
06/17/2010WO2010066075A1 The use of hylotelephin in preparing medicaments for treating hbeag positive chronic hepatitis b in human
06/17/2010WO2010047737A3 Antimicrobial indoline compounds for treatment of bacterial infections
06/17/2010WO2010044919A3 Smallpox dna vaccine and the antigens therein that elicit an immune response
06/17/2010WO2010041141A3 Oil-based foamable carriers and formulations
06/17/2010WO2010033444A8 Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, a potent hcv inhibitor
06/17/2010WO2010031801A3 Composition and methods for modulating toll-like receptor activity
06/17/2010WO2010029104A3 Use of a pharmaceutical composition for the local treatment of infections, and medical product
06/17/2010WO2009053339A3 Cholesterol derivatives of inhibitors of viral fusion
06/17/2010US20100152301 Treatment of Viral Infections
06/17/2010US20100152244 Self-emulsifying formulation of tipranavir for oral administration
06/17/2010US20100152240 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
06/17/2010US20100152230 Hydroxy substituted 1h-imidazopyridines and methods
06/17/2010US20100152229 Process for the Synthesis of Moxifloxacin Hydrochloride
06/17/2010US20100152214 Novel pyrimidinecarboxamide derivatives
06/17/2010US20100152212 Preq1 riboswitches and methods and compositions for use of and with preq1 riboswitches
06/17/2010US20100152211 Inhibitors of human phosphatidylinositol 3-kinase delta
06/17/2010US20100152200 Alphavirus inhibitors and uses thereof